Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mixed mesodermal sarcoma of the ovary

W Hernandez, P J DiSaia, C P Morrow

    Obstetrics and Gynecology
    |January 1, 1977
    PubMed
    Summary

    This study reports three mixed mesodermal sarcoma (MMS) cases and reviews 90 literature cases. These rare ovarian tumors often present at advanced stages, posing therapeutic challenges, particularly in postmenopausal women.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Is endocerevical sampling necessary?

    Journal of lower genital tract disease·2015
    Same author

    Colposcoping patients after leep.

    Journal of lower genital tract disease·2015
    Same author

    Response 3.

    Journal of lower genital tract disease·2015
    Same author

    Utility of risk-weighted surgical-pathological factors in early-stage cervical cancer.

    British journal of cancer·2013
    Same author

    Management of recurrent cervical cancer: a review of the literature.

    Surgical oncology·2012
    Same author

    New classification system of radical hysterectomy: emphasis on a three-dimensional anatomic template for parametrial resection.

    Gynecologic oncology·2011

    Area of Science:

    • Gynecologic Oncology
    • Pathology
    • Oncologic Surgery

    Background:

    • Mixed mesodermal sarcoma (MMS) is a rare and aggressive ovarian malignancy.
    • These tumors predominantly affect postmenopausal, nulliparous women.
    • MMS often presents at advanced stages (Stage III), complicating treatment.

    Observation:

    • This study reports three new cases of ovarian MMS and reviews 90 additional cases from the English literature.
    • Analysis focused on clinical features, patient outcomes, and treatment effectiveness.

    Findings:

    • MMS predominantly affects postmenopausal women, often nulliparous.
    • The disease is frequently diagnosed at an advanced stage (Stage III), complicating treatment.
    • Histogenesis and a novel classification for ovarian sarcomas are discussed.

    Implications:

    • The findings highlight the challenges in managing advanced-stage ovarian MMS.
    • A proposed new classification may aid in better understanding and categorizing ovarian sarcomas.
    • Further research into therapeutic strategies for advanced ovarian sarcomas is warranted.

    Related Experiment Videos